NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

Partnership

AI, Data & Robots (ADRA)

AI, Data & Robots (ADRA)

Partnership website: https://adr-association.eu/

The AI, Data and Robotics (ADR) partnership brings together industry, academia and the European Commission to
pursue innovative solutions on a large scale, pooling efforts, resources and investments to generate long-term positive impact, boost European competitiveness and technological sovereignty, as well as create jobs and growth.
The general objectives of the co-programmed European Partnership are:

  • secure European’s sovereignty over AI, data and robotics technologies and know how (position and control perspective dimension);
  • establish European leadership in AI, data and robotics technologies with high environmental, social and economic impact (with focus on technology and innovation dimensions);
  • reinforce Europe’s strong and global competitive position in AI, data and robotics (market dimension).

The partnership will boost Europe’s competitiveness, societal well-being and environmental leadership, as leading
the world in researching, developing and deploying value-driven trustworthy AI, data and robotics based on European
fundamental rights, principles and values.

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

How to use partnerships?

  • orientation
    Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.
  • networking
    Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.
  • ecosystem analysis
    Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.
  • steering the agenda
    Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.